FABAD J. Pharm. Sci.
ISSN 1300-4182
Copyright © 2008 FABAD. All rights reserved
INSTRUCTIONS FOR AUTHORS SCOPE OF THE JOURNAL
The journal publishes original, innovative research articles, review articles, short communications, scientific reports in all fields of pharmaceutical and related health sciences.
It is recommended that all articles do not exceed a total of 15 double spaced pages including references, tables, figure legends and figures using font size 12.
Review articles are allowed up to 25 pages. The publication language is English.
CONFLICT OF INTEREST
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work.
DECLARATION OF SUBMISSION
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, without the written consent of the copyright-holder.
SUBMISSION
Submission to this journal proceeds only by e-mail to the editor (fabadankara@gmail.com). All correspondences, including notification of the Editor's decision and requests for revision takes place by e-mail.
Research Articles
Articles in all fields of pharmaceutical and related health sciences (physical, chemical, biological, medical, dental, social, etc.), presenting an original research could be consider for publication.
Scientific Reviews
An updated comprehensive review, with sufficient number of scientific articles including original paper(s) of the author(s) on a subject, evaluating and discussing the results could be consider for publication.
Short Communications
Rapid announcement of the results of a continuing research, not exceeding two printed pages can be submitted as a short communication.
Scientific Reports
a) Articles dealing with important scientific pharmaceutical events in Turkey and in the world, b) Recent equipment and materials,
c) Short information and reports on the pharmaceutical congresses, conferences, symposia, etc., d) English summaries of Ph.D. theses in pharmaceutical sciences,
e) Reviews of scientific books in pharmaceutical sciences,
f ) Reviews on recently published scientific journals, etc. can be submitted as a short communication.
Preparation of manuscripts
1. Text should be typed double spaced in A4 format with a margin of 2 cm on each side of the page using a word processor, MS Office for Windows.
2. Following the article title, author names and affiliations should be stated. All affiliations should be stated with a lower-case superscript letter. Provide the full postal address of each affiliation, including the country name, and e-mail address of the corresponding author.
3. A cover page should be provided with the title of article, author name and affiliations (including fax, telephone, e-mail addresses) of the author to whom all correspondence should be directed. Manuscripts submitted should have a separate letter including the signatures of each author.
4. The Declaration of Helsinki as amended in Seoul 2008 for humans, and the European Community guidelines and Turkish Official guidelines as accepted principles for the use of experimental animals, must be also adhered to.
5. Sections of the manuscripts should adhere to the following sequence:
Summary
It should be written in Turkish and English, not exceeding 200 words, title and keywords should be given in both languages. List of keywords (maximum 5) should be provided under the summaries. The aim of the study, methods, results and conclusion should be described briefly.
Introduction
The objective of the work should be stated and an adequate background provided, avoiding a detailed literature survey or a summary of the results.
Material and methods
Sufficient detail should be provided to allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications should be described.
Results
Results should be clear and concise.
Discussion
This should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature.
Conclusions
The main conclusions of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of a Discussion or Results and Discussion section.
References
References should be numbered consecutively in the order in which they are cited. The reference list is given in the order in which they appear in the text.
Articles:
Stalcup AM, Chang SC, Armstrong DW, Pitha J. (s)-2-Hydroxypropyl-β-cyclodextrin, a new chiral stationary phase for reversed–phase liquid chromatography. J Chromatogr A 513: 181-194, 1990.
Books:
Van de Waterbeemd H. Quantitative approaches to structure-activity relationships. In: Wermuth CG, editor. The practice of medicinal chemistry. 4th ed. Great Britain: Academic Press; 2001. p. 367-89. Watson, DG. Pharmaceutical analysis. 1st ed. Chine: Churchill Livingstone; 1999.
Dissertations:
Karakurt A. Studies on synthesis, enantiomeric separation, anticonvulsant and antimicrobial activities of some new 2-acetylnaphthalene derivatives [dissertation]. Ankara (Turkey): Hacettepe University Institute of Health Sciences; 2004.
Patents:
Larsen CE, Trip R, Johnson CR, inventors; Novoste Corporation, assignee. Methods for procedures related to the electrophysiology of the heart. US patent 5,529,067. 1995 Jun 25.
Electronic articles:
Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis {serial online] 1995 Jan-Mar [cited 1996 Jun 5];
1(1):[24 screens]. Available from: URL: http://www.cdc.gov/ncidod/EID/eid.htm Figures and graphics
Figures, graphics and photographs should be in TIFF or JPEG format submitted as a separate file. Figure legends should be written on a separate page.
Tables
Tables should be submitted on a separate page.
